Tetraspanins play a well-established role in cancer development and progression (Hemler 2014), and CD37-directed targeted therapies are currently under investigation in clinical trials in patients with B cell malignancies (Zhao et al. 2007; Robak et al. 2009; Rafiq et al. 2013). The gene discussed is CD37; the disease is cancer.